全球消化道出血治疗市场规模、份额、趋势和成长分析报告（2026-2034）

预计消化道出血治疗市场规模将从 2025 年的 9.6 亿美元成长到 2034 年的 19.3 亿美元，2026 年至 2034 年的复合年增长率为 8.06%。

随着胃肠道疾病、溃疡和大肠癌发生率的上升，治疗胃肠道出血的市场也持续成长。人口老化和不健康的生活方式，包括过量饮酒和不良饮食习惯，都是导致发病率上升的因素。诊断技术的进步使得早期检测成为可能，从而增加了对有效治疗方案的需求。

关键成长要素包括微创内视镜手术的引进、止血装置的改善以及发展中地区医疗基础设施的扩建。药物治疗、输血服务和先进外科技术的进步正在改善治疗效果。公众意识的提高和急救医疗服务的改善也进一步推动了全球市场的发展。

预计未来成长将主要由内视镜治疗技术的创新和标靶药物的研发推动。医疗保健支出的增加和保险覆盖范围的扩大有望改善患者获得治疗的机会。随着医疗技术的进步和患者疗效的提高，消化道出血治疗市场预计将保持长期稳定的成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球消化道出血治疗市场：依产品分类

• 市场分析、洞察与预测
• 内视镜止血装置
• 内视镜机械和设备
• 内视镜热凝装置
• 闭合装置
• 其他的

第五章 全球消化道出血治疗市场：依胃肠道细分市场划分

• 市场分析、洞察与预测
• 上消化道
• 下消化道

第六章：全球消化道出血治疗市场：依发病时间划分

• 市场分析、洞察与预测
• 急性
• 慢性的

第七章 全球消化道出血治疗市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心（ASC）
• 其他的

第八章 全球消化道出血治疗市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Medtronic PLC
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pfizer Inc
  • STERIS PLC
  • US Medical Innovations

The Gastrointestinal Bleeding Treatment Market size is expected to reach USD 1.93 Billion in 2034 from USD 0.96 Billion (2025) growing at a CAGR of 8.06% during 2026-2034.

The gastrointestinal bleeding treatment market is witnessing growth due to the increasing incidence of gastrointestinal disorders, ulcers, and colorectal cancers. Aging populations and unhealthy lifestyles, including excessive alcohol consumption and poor dietary habits, are contributing to higher prevalence rates. Advances in diagnostic techniques are enabling early detection, thereby boosting demand for effective treatment solutions.

Key drivers include the adoption of minimally invasive endoscopic procedures, improved hemostatic devices, and expanding healthcare infrastructure in developing regions. Pharmaceutical therapies, blood transfusion services, and advanced surgical techniques are enhancing treatment outcomes. Growing awareness and improved emergency care services are further supporting market expansion globally.

Future growth will be driven by innovations in endoscopic therapies and targeted drug development. Increased healthcare spending and insurance coverage are expected to improve patient access to treatment. As medical technologies evolve and patient outcomes improve, the gastrointestinal bleeding treatment market is anticipated to maintain steady long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Endoscopic Hemostatic Devices
• Endoscopic Mechanical Devices
• Endoscopic Thermal Devices
• Closure Devices
• Other

By GI Tract Division

• Upper GI tract
• Lower GI tract

By Onset

• Acute
• Chronic

By End-use

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other

COMPANIES PROFILED

• Boston Scientific Corporation, Conmed Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc, STERIS PLC, US Medical Innovations
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Endoscopic Hemostatic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Endoscopic Mechanical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Endoscopic Thermal Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY GI TRACT DIVISION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Gi Tract Division
• 5.2. Upper GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Lower GI tract Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY ONSET 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Onset
• 6.2. Acute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chronic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Gi Tract Division
  • 8.2.3 By Onset
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Gi Tract Division
  • 8.3.3 By Onset
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Gi Tract Division
  • 8.4.3 By Onset
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Gi Tract Division
  • 8.5.3 By Onset
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Gi Tract Division
  • 8.6.3 By Onset
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GASTROINTESTINAL BLEEDING TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Scientific Corporation
  • 10.2.2 Conmed Corporation
  • 10.2.3 Cook Group
  • 10.2.4 ERBE Elektromedizin GmbH
  • 10.2.5 Medtronic PLC
  • 10.2.6 Olympus Corporation
  • 10.2.7 Ovesco Endoscopy AG
  • 10.2.8 Pfizer Inc
  • 10.2.9 STERIS PLC
  • 10.2.10 US Medical Innovations